InflaRx N.V. (Nasdaq: IFRX) (the 'Company”), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting ...

Performance, design, and atmosphere combine through a 1 SOUND system.

PathAI's best-in-class Image Management System (IMS) with advanced AI analysis and workflow capabilities will complement Roche's digital pathology portfolio to drive laboratory efficiencyCombining Roc ...

Calorie restriction lowers C3, an immune protein tied to aging and inflammation, improving health without requiring weight ...

PRESIDENT Dr. Irfaan Ali has signalled a major shift in the country’s transportation strategy, stating that the government is ...

Drax boss Will Gardiner says he is “excited” about further potential renewable energy investments by the company after it put ...

The AN/ALR-69A radar warning receiver is the C-17's 'ears' in a spectrum filled with invisible emissions, detecting, and ...

The term “affordable mass” entered public defense discourse in 2021 as a munitions concept, which the Air Force adopted in ...

C3G and IC-MPGN can be difficult to diagnose because they are so rare and their symptoms are vague and nonspecific. A kidney biopsy is considered the gold standard and usually needed to confirm the ...

Complement 3 glomerulopathy (C3G) is a rare kidney disease that is also considered an autoimmune disorder. There is no single cure for C3G, but several treatments may slow disease progression, protect ...

There are two types of complement 3 glomerulopathy: dense deposit disease (DDD) and C3 glomerulonephritis (C3GN). DDD often begins earlier in life and may progress more quickly. Both are linked to an ...

Get the live share price of Apellis Pharmaceuticals Inc (APLS), including intraday charts, historical performance, key ...